We thus propose that this combined shift in CAF composition ultimately alters the dynamics of tumor-infiltrating lymphocyte spatiality and activation, and facilitates the generation of functional immunity secondary to TGFβ-inhibition. The gene discussed is TGFB1; the disease is neoplasm.